Bio-Gate AG (FRA:BIG1)

Bio-Gate AG Statistics

Total Valuation

Bio-Gate AG has a market cap or net worth of EUR 6.68 million. The enterprise value is 6.53 million.

Market Cap	6.68M
Enterprise Value	6.53M

Important Dates

The next estimated earnings date is Tuesday, June 9, 2026.

Earnings Date	Jun 9, 2026
Ex-Dividend Date	n/a

Share Statistics

Bio-Gate AG has 10.19 million shares outstanding.

Current Share Class	10.19M
Shares Outstanding	10.19M
Shares Change (YoY)	n/a
Shares Change (QoQ)	+5.34%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.86
PB Ratio	4.18
P/TBV Ratio	22.36
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-5.61
EV / Sales	0.84
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-6.29

Financial Position

The company has a current ratio of 1.93, with a Debt / Equity ratio of 0.31.

Current Ratio	1.93
Quick Ratio	0.82
Debt / Equity	0.31
Debt / EBITDA	n/a
Debt / FCF	-0.48
Interest Coverage	-12.77

Financial Efficiency

Return on equity (ROE) is -71.99% and return on invested capital (ROIC) is -32.74%.

Return on Equity (ROE)	-71.99%
Return on Assets (ROA)	-16.39%
Return on Invested Capital (ROIC)	-32.74%
Return on Capital Employed (ROCE)	-34.90%
Weighted Average Cost of Capital (WACC)	4.88%
Revenue Per Employee	151,743
Profits Per Employee	-22,843
Employee Count	51
Asset Turnover	1.80
Inventory Turnover	2.65

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -35.71% in the last 52 weeks. The beta is -0.01, so Bio-Gate AG's price volatility has been lower than the market average.

Beta (5Y)	-0.01
52-Week Price Change	-35.71%
50-Day Moving Average	0.64
200-Day Moving Average	0.74
Relative Strength Index (RSI)	49.60
Average Volume (20 Days)	331

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Bio-Gate AG had revenue of EUR 7.74 million and -1.16 million in losses. Loss per share was -0.11.

Revenue	7.74M
Gross Profit	4.31M
Operating Income	-1.13M
Pretax Income	-1.22M
Net Income	-1.16M
EBITDA	-893,577
EBIT	-1.13M
Loss Per Share	-0.11

Balance Sheet

The company has 704,933 in cash and 493,535 in debt, with a net cash position of 211,398 or 0.02 per share.

Cash & Cash Equivalents	704,933
Total Debt	493,535
Net Cash	211,398
Net Cash Per Share	0.02
Equity (Book Value)	1.60M
Book Value Per Share	0.15
Working Capital	1.33M

Cash Flow

In the last 12 months, operating cash flow was -1.01 million and capital expenditures -31,000, giving a free cash flow of -1.04 million.

Operating Cash Flow	-1.01M
Capital Expenditures	-31,000
Depreciation & Amortization	235,000
Net Borrowing	760,000
Free Cash Flow	-1.04M
FCF Per Share	-0.10

Margins

Gross margin is 55.65%, with operating and profit margins of -14.58% and -15.05%.

Gross Margin	55.65%
Operating Margin	-14.58%
Pretax Margin	-15.75%
Profit Margin	-15.05%
EBITDA Margin	-11.55%
EBIT Margin	-14.58%
FCF Margin	n/a

Dividends & Yields

Bio-Gate AG does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-17.45%
FCF Yield	-15.55%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on November 26, 2012. It was a reverse split with a ratio of 0.25.

Last Split Date	Nov 26, 2012
Split Type	Reverse
Split Ratio	0.25

Scores

Bio-Gate AG has an Altman Z-Score of -1.68 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-1.68
Piotroski F-Score	3